Meihua Intl Med Technologies
13F holders, Q4 2024 (December 31)9holders +2
5new positions
3sold out
$0.34avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Meihua Intl Med Technologies in their 13F filings, up 2 from Q3 2024. 5 opened new positions and 3 sold out. The largest holders were UBS Group AG ($21K), Virtu Financial LLC ($14K) and XTX Topco Ltd ($12K).
- Company
- Meihua Intl Med Technologies
- CUSIP
- G5966G108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $56K |
| Exits | 3 | $2.4M |
All 13F filers, Q3 2024 → Q4 2024: 165,327 shares bought and 2,389,122 shares sold, net −2,223,795 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| UBS Group AG | 0.00% | Reduce -52.0% | 62,279 | $21K |
| Virtu Financial LLC | 0.00% | New | 41,357 | $14K |
| XTX Topco Ltd | 0.00% | New | 34,928 | $12K |
| HRT Financial LP | 0.00% | New | 33,441 | $11K |
| Two Sigma Investments, LP | 0.00% | New | 30,429 | $11K |
| Jane Street Group, LLC | 0.00% | New | 25,172 | $9K |
| Geode Capital Management, LLC | 0.00% | Reduce -14.1% | 14,394 | $5K |
| Two Sigma Securities, LLC | 0.00% | Reduce -54.4% | 11,582 | $4K |
| Morgan Stanley | 0.00% | No change | 2,786 | $961 |
"% of holder's portfolio" is MEIHUA INTL MED TECHNOLOGIES's weight in each manager's 13F, not the share of Meihua Intl Med Technologies the manager owns.